Research Paper
Elevation of cerebrospinal fluid interleukin-1β in bipolar disorder
Johan Söderlund, Sara K. Olsson, Martin Samuelsson, Lilian Walther-Jallow, Christian Johansson, Sophie Erhardt, Mikael Landén and Göran Engberg
J Psychiatry Neurosci March 01, 2011 36 (2) 114-118; DOI: https://doi.org/10.1503/jpn.100080
Johan Söderlund
Söderlund, Olsson, Erhardt, Engberg — Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm; Samuelsson — Department of Clinical and Experimental Medicine, Section of Psychiatry, Faculty of Health Sciences, Linköping University, Linköping; Walther-Jallow — Centre for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm; Johansson, Landén — Department of Clinical Neuroscience, Karolinska Institutet, Stockholm; Landén — Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
MD, PhDSara K. Olsson
Söderlund, Olsson, Erhardt, Engberg — Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm; Samuelsson — Department of Clinical and Experimental Medicine, Section of Psychiatry, Faculty of Health Sciences, Linköping University, Linköping; Walther-Jallow — Centre for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm; Johansson, Landén — Department of Clinical Neuroscience, Karolinska Institutet, Stockholm; Landén — Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
MScMartin Samuelsson
Söderlund, Olsson, Erhardt, Engberg — Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm; Samuelsson — Department of Clinical and Experimental Medicine, Section of Psychiatry, Faculty of Health Sciences, Linköping University, Linköping; Walther-Jallow — Centre for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm; Johansson, Landén — Department of Clinical Neuroscience, Karolinska Institutet, Stockholm; Landén — Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
MDLilian Walther-Jallow
Söderlund, Olsson, Erhardt, Engberg — Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm; Samuelsson — Department of Clinical and Experimental Medicine, Section of Psychiatry, Faculty of Health Sciences, Linköping University, Linköping; Walther-Jallow — Centre for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm; Johansson, Landén — Department of Clinical Neuroscience, Karolinska Institutet, Stockholm; Landén — Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
PhDChristian Johansson
Söderlund, Olsson, Erhardt, Engberg — Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm; Samuelsson — Department of Clinical and Experimental Medicine, Section of Psychiatry, Faculty of Health Sciences, Linköping University, Linköping; Walther-Jallow — Centre for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm; Johansson, Landén — Department of Clinical Neuroscience, Karolinska Institutet, Stockholm; Landén — Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
MDSophie Erhardt
Söderlund, Olsson, Erhardt, Engberg — Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm; Samuelsson — Department of Clinical and Experimental Medicine, Section of Psychiatry, Faculty of Health Sciences, Linköping University, Linköping; Walther-Jallow — Centre for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm; Johansson, Landén — Department of Clinical Neuroscience, Karolinska Institutet, Stockholm; Landén — Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
PhDMikael Landén
Söderlund, Olsson, Erhardt, Engberg — Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm; Samuelsson — Department of Clinical and Experimental Medicine, Section of Psychiatry, Faculty of Health Sciences, Linköping University, Linköping; Walther-Jallow — Centre for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm; Johansson, Landén — Department of Clinical Neuroscience, Karolinska Institutet, Stockholm; Landén — Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
MD, PhDGöran Engberg
Söderlund, Olsson, Erhardt, Engberg — Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm; Samuelsson — Department of Clinical and Experimental Medicine, Section of Psychiatry, Faculty of Health Sciences, Linköping University, Linköping; Walther-Jallow — Centre for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm; Johansson, Landén — Department of Clinical Neuroscience, Karolinska Institutet, Stockholm; Landén — Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
PhDArticle Figures & Tables
Figures
In this issue
Article tools
Respond to this article
Elevation of cerebrospinal fluid interleukin-1β in bipolar disorder
Johan Söderlund, Sara K. Olsson, Martin Samuelsson, Lilian Walther-Jallow, Christian Johansson, Sophie Erhardt, Mikael Landén, Göran Engberg
J Psychiatry Neurosci Mar 2011, 36 (2) 114-118; DOI: 10.1503/jpn.100080
Related Articles
- No related articles found.